# 04. Apex HealthTech: Executive Audit Memorandum & Remediation Roadmap

**TO:** Audit Committee, Chief Executive Officer (CEO), Chief Information Officer (CIO)  
**FROM:** Information Security & IT Audit Team  
**DATE:** September 2026  
**SUBJECT:** Comprehensive IT General Controls (ITGC) & Enterprise Risk Assessment Findings  

---

## 1. Executive Summary
During Q3 2026, the Internal Audit & Cybersecurity Assessment team conducted an IT General Controls (ITGC) evaluation and risk assessment of the **Apex HealthTech Cloud Analytics Platform**. The primary objective was to validate the design and operational effectiveness of technical controls safeguarding Electronic Protected Health Information (ePHI) in alignment with **SOC 2 Type II**, **ISO 27001**, and **HIPAA Security Rule** standards.

**Overall Audit Opinion:** **Satisfactory with Minor Remediation**.  
The core cloud infrastructure, network segmentation, and database encryption controls demonstrate robust maturity. One low-risk operational deficiency regarding third-party contractor deprovisioning was identified and remediated during the audit period.

---

## 2. Key Findings & Business Impact Summary

| Control Area | Operational Finding | Business & Compliance Risk | Status / Remediation Action |
| :--- | :--- | :--- | :--- |
| **Identity & Access Management** | Contractor account remained active for 72 hours post-contract expiration (Control AC-02). | Potential unauthorized access or privilege accumulation; minor SOC 2 CC6.2 deficiency. | **Remediated:** Implemented automated webhook synchronization between BambooHR and Active Directory for instant deprovisioning. |
| **Data Protection & Database Tier** | Managed PostgreSQL database is fully isolated within private subnets with automated KMS encryption (Control OP-01). | Ensures full compliance with HIPAA encryption standards (§ 164.312) and prevents public exposure. | **Effective:** Validated automated 35-day backup retention and verified quarterly restoration testing. |
| **Change Management & CI/CD** | Separation of duties enforced; developers cannot make direct production modifications (Control CM-02). | Eliminates risk of unauthorized code deployment or clinical data manipulation. | **Effective:** Production deployments strictly managed through automated peer-reviewed pipelines. |

---

## 3. Residual Risk Profile
Following the assessment and remediation of identified operational gaps, Apex HealthTech’s enterprise risk profile remains well within the Board’s approved risk tolerance:
* **High Inherent Risks (Ransomware, Database Exposure):** Successfully reduced to **Low Residual Risk** through endpoint EDR, automated configuration drift detection, and network isolation.
* **Third-Party Vendor Exposure:** Addressed via mandatory vendor risk assessments (VRM) and automated API credential rotation cycles.

---

## 4. Strategic Recommendations for Management
1. **Automated Continuous Compliance:** Expand AWS Config rules across all cloud accounts to detect any unauthorized modifications to database security groups in real-time.
2. **Quarterly Privileged Access Recertification:** Maintain automated quarterly access review campaigns in Microsoft Entra ID for all users with elevated administrative rights.
3. **Third-Party Risk Reviews:** Require SOC 2 Type II reports from all upstream and downstream API vendors annually prior to contract renewal.
